Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: the LUNAR Study

被引：0
|
作者：
Peace, James H. [1 ]
Medeiros, Felipe A. [2 ]
Martin, Keith R. [3 ,4 ]
Vittitow, Jason L. [5 ]
Weinreb, Robert N. [2 ,6 ]
机构：
[1] United Med Res Inst, Inglewood, CA USA
[2] Univ Calif San Diego, Shiley Eye Inst, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA
[3] Addenbrookes Hosp, Eye Dept, Cambridge, England
[4] Cambridge NIHR Biomed Res Ctr, Cambridge, England
[5] Bausch Lomb, Clin Affairs, Bridgewater, NJ USA
[6] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3035
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Latanoprostene Bunod 0.024% in Patients with Open-Angle Glaucoma Switched from Prior Pharmacotherapy: A Retrospective Chart Review
    Okeke, Constance O.
    Cothran, Nora Lee
    Brinkley, Desirae A.
    Rahmatnejad, Kamran
    Rodino, Frank J.
    Deom, James E.
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 409 - 422
  • [22] LEVOBUNOLOL VS TIMOLOL FOR OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION
    CINOTTI, A
    CINOTTI, D
    GRANT, W
    JACOBS, I
    GALIN, M
    SILVERSTONE, D
    SHIN, D
    ESTERS, J
    LEE, J
    BOUCHEY, R
    NOVACK, G
    DUZMAN, E
    LUE, J
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1985, 99 (01) : 11 - 17
  • [23] BUDGET IMPACT ANALYSIS OF TAFLUPROST/TIMOLOL MALEATE FOR LOWERING INTRAOCULAR PRESSURE (TOP) IN ADULT PATIENTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION IN BULGARIA
    Djambazov, S.
    Slavchev, G.
    Encheva-Malinova, M.
    Vekov, T.
    VALUE IN HEALTH, 2018, 21 : S240 - S240
  • [24] Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension
    Day, DG
    Schacknow, PN
    Wand, M
    Sharpe, ED
    Stewart, JA
    Leech, J
    Stewart, WC
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (02) : 138 - 143
  • [25] A comparison of the diurnal IOP-lowering efficacy of levobetaxolol 0.5% vs. brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension.
    DuBiner, HB
    Kothe, HC
    Sharma, V
    Mallick, S
    Andrew, RM
    Sullivan, EK
    Weiner, AL
    DeSantis, LM
    Krueger, S
    Bergamini, MVW
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S417 - S417
  • [26] Timolol hemihydrate vs timolol maleate to treat ocular hyper-tension and open-angle glaucoma
    DuBiner, HB
    Hill, R
    Kaufman, H
    Keates, EU
    Zimmerman, TJ
    Mandell, AI
    Mundorf, TK
    Bahr, RL
    Schwartz, LW
    Towey, AW
    Hurvitz, LM
    Starita, RJ
    Sassani, JW
    Ropo, A
    Gunn, R
    Stewart, WC
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1996, 121 (05) : 522 - 528
  • [27] COST-MINIMIZATION ANALYSIS OF TAFLUPROST/TIMOLOL MALEATE FOR LOWERING INTRAOCULAR PRESSURE (TOP) IN ADULT PATIENTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION IN BULGARIA
    Djambazov, S.
    Slavchev, G.
    Encheva-Malinova, M.
    Vekov, T.
    VALUE IN HEALTH, 2018, 21 : S241 - S241
  • [28] A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF2α metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension
    Nordmann, JP
    Rouland, JF
    Mertz, BP
    CURRENT MEDICAL RESEARCH AND OPINION, 1999, 15 (02) : 87 - 93
  • [29] Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naive Patients with Open-Angle Glaucoma
    Okeke, Constance O.
    Burstein, Eitan S.
    Trubnik, Valerie
    Deom, James E.
    Cooper, Michael S.
    Brinkley, Desirae A.
    Thimons, J. James
    Kabiri, Alexander J.
    Gelb, Kerry M.
    OPHTHALMOLOGY AND THERAPY, 2020, 9 (04) : 1041 - 1053
  • [30] Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study
    Tadashi Nakano
    Shiro Mizoue
    Nobuo Fuse
    Aiko Iwase
    Shun Matsumoto
    Keiji Yoshikawa
    Advances in Therapy, 2015, 32 : 823 - 837
12345